SIGLEC12 and prostate carcinoma: To explore molecular mechanisms of Siglec‐XII in cancer progression, we compared RNA expression patterns between SIGLEC12 null PC‐3 prostate cancer cells with and without transfection with a construct encoding Siglec‐XII.